Last reviewed · How we verify

NCT03740347: RHUMEDOL

Chronic Non-inflammatory Pains in Rheumatopediatrics

Withdrawn Last updated 3 April 2026
What this trial tests

trial testing Questionnaires in Juvenile Idiopathic Arthritis. Withdrawn.

Timeline
6 November 2018
Primary endpoint
6 November 2018
6 November 2018

Quick facts

Lead sponsorAssistance Publique - Hôpitaux de Paris
StatusWithdrawn
Study typeOBSERVATIONAL
Start date6 November 2018
Primary completion6 November 2018
Estimated completion6 November 2018
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Assistance Publique - Hôpitaux de Paris — full company profile →

Who can join

Adults 12 to 17, any sex, with Juvenile Idiopathic Arthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine the frequency of chronic pain in adolescent with juvenile idiopathic arthritis, especially when the disease is inactive or with minimal activity. Secondary objectives are, first to determine intensity of pain and its repercussion in daily life and second to determine risk factor of chronic pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Questionnaires

Trials testing the same drug.

Other recruiting trials for Juvenile Idiopathic Arthritis

Currently open trials in the same condition.

Other Assistance Publique - Hôpitaux de Paris trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03740347.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing